Skip header and navigation

Narrow By

13 records – page 1 of 1.

The AST handbook of transplant infections

https://libcat.nshealth.ca/en/permalink/provcat25634
edited by Deepali Kumar, Atul Humar [...] ; on behalf of the American Society of Transplantation Infectious Diseases Community of Practice. --West Sussex, England: Wiley-Blackwell , 2011.
Call Number
WO 660 A852 2011
Location
Dickson Building
Call Number
WO 660 A852 2011
Other Authors
Kumar, Deepali
Humar, Atul
Other Authors
American Society of Transplantation. Infectious Diseases Community of Practice
Responsibility
edited by Deepali Kumar, Atul Humar [...] ; on behalf of the American Society of Transplantation Infectious Diseases Community of Practice
Place of Publication
West Sussex, England
Publisher
Wiley-Blackwell
Date of Publication
2011
Physical Description
xv, 171 p.
ISBN
9780470658277
0470658274
Subjects (MeSH)
Communicable Disease Control
Immunosuppressive agents - adverse effects
Postoperative Complications - prevention & control
Bacterial Infections - therapy
Mycoses - therapy
Virus Diseases - therapy
Subjects (LCSH)
Communicable diseases--Handbooks, manuals, etc
Transplantation of organs, tissues, etc.--Complications--Handbooks, manuals, etc
Format
Book
Publication Type
Handbook
Location
Dickson Building
Loan Period
3 weeks
Less detail

Azathioprine and Mercaptopurine Therapy

https://libcat.nshealth.ca/en/permalink/chpams35565
Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1079
Available Online
View Pamphlet
This pamphlet will help you decide if azathioprine (Imuran®) or mercaptopurine therapy is right for you. The pamphlet explains what azathioprine (AZA) and mercaptopurine (6-MP) are, how well they work, as well as serious and less serious side-effects. The pamphlet also includes a list of what you can do to lower the chances of side-effects.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.): digital, PDF file
Subjects (MeSH)
Immunosuppressive Agents
Azathioprine
Mercaptopurine
Subjects (LCSH)
Immunosuppressive agents
Specialty
Medications
Abstract
This pamphlet will help you decide if azathioprine (Imuran®) or mercaptopurine therapy is right for you. The pamphlet explains what azathioprine (AZA) and mercaptopurine (6-MP) are, how well they work, as well as serious and less serious side-effects. The pamphlet also includes a list of what you can do to lower the chances of side-effects.
Notes
Previous title: Azathioprine (Imuran) therapy
Responsibility
Prepared by: Nova Scotia Collaborative Inflammatory Bowel Disease Program
Pamphlet Number
1079
Less detail

Azathioprine (Imuran and generic brands) and 6-MP (Purinethol and generic brands)

https://libcat.nshealth.ca/en/permalink/chpams36867
IWK. Gastroenterology, Nutrition & Paediatric Health Psychology Team, IWK. Pediatric Medical Services. Halifax, NS: IWK Health Centre , 2019.
Pamphlet Number
PL-0204
Available Online
View Pamphlet
Information about Azathioprine (Imuran) and 6-MP (Purinethol) for patients and families.
Available Online
View Pamphlet
Corporate Author
IWK. Gastroenterology, Nutrition & Paediatric Health Psychology Team
IWK. Pediatric Medical Services
Alternate Title
A Patient Guide
Place of Publication
Halifax, NS
Publisher
IWK Health Centre
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document : digital, PDF file
Subjects (MeSH)
Immunosuppressive Agents
Subjects (LCSH)
Immunosuppressive agents
Abstract
Information about Azathioprine (Imuran) and 6-MP (Purinethol) for patients and families.
Responsibility
IWK Gastroenterology, Nutrition & Paediatric Health Psychology Team, Halifax, NS
Pamphlet Number
PL-0204
Zone
All Zones
Less detail

Chronic graft versus host disease : interdisciplinary management

https://libcat.nshealth.ca/en/permalink/provcat27729
Vogelsang, Georgia B. --Cambridge: Cambridge University Press , 2009.
Available Online
View e-Book
Location
Online
Available Online
View e-Book
Author
Vogelsang, Georgia B
Other Authors
Pavletic, Steven Z
Place of Publication
Cambridge
Publisher
Cambridge University Press
Date of Publication
2009
Physical Description
422 p.
Series Title
Cambridge medicine
ISBN
9780511576751 (ebook)
Subjects (MeSH)
Graft vs Host Disease - therapy
Chronic Disease - therapy
Immunosuppression
Immunosuppressive Agents
Format
e-Book
Location
Online
Less detail

Cytomegalovirus (CMV)

https://libcat.nshealth.ca/en/permalink/chpams36606
Nova Scotia Health Authority. Kidney Transplant Clinic. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
1999
Available Online
View Pamphlet
The cytomegalovirus (CMV) is a common virus found in people of all ages. People who have had a kidney transplant and are taking immunosuppressive medications are at risk. The pamphlet outlines the symptoms, how the virus is diagnosed, and how it is treated.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Kidney Transplant Clinic
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([1] p.) : digital, PDF file
Subjects (MeSH)
Cytomegalovirus
Kidney Transplantation - adverse effects
Immunosuppressive Agents - adverse effects
Subjects (LCSH)
Cytomegalovirus infections
Kidneys--Transplantation
Immunosuppressive agents
Specialty
Nephrology
Medications
Abstract
The cytomegalovirus (CMV) is a common virus found in people of all ages. People who have had a kidney transplant and are taking immunosuppressive medications are at risk. The pamphlet outlines the symptoms, how the virus is diagnosed, and how it is treated.
Responsibility
Prepared by: Kidney Transplant Clinic
Pamphlet Number
1999
Less detail

Immune modulation and anti-inflammatory therapy in ocular disorders : IOIS guidelines

https://libcat.nshealth.ca/en/permalink/provcat34026
Uwe Pleyer, Jorge L. Alió, Talin Barisani-Asenbauer, Phuc Le Hoang, Narsing A. Rao, editors. --Heidelberg: Springer , c2014.
Available Online
View e-Book
Location
Online
These guidelines, compiled by a panel of clinicians and scientists with a high level of expertise, aim to provide readers with the most up-to-date and comprehensive instructions on the treatment and prevention of ocular inflammation. All of the recommendations are explicitly linked to supporting evidence and graded according to the strength of that evidence, and the editors have made every effort to ensure that chapters are of a consistently high methodological quality. The guidelines for each …
Available Online
View e-Book
Corporate Author
International Ocular Inflammation Society
Other Authors
Pleyer, Uwe
Responsibility
Uwe Pleyer, Jorge L. Alió, Talin Barisani-Asenbauer, Phuc Le Hoang, Narsing A. Rao, editors
Place of Publication
Heidelberg
Publisher
Springer
Date of Publication
c2014
Physical Description
1 online resource (xiii, 244 pages)
ISBN
9783642543500 (electronic bk.)
9783642543494
Subjects (MeSH)
Eye Diseases - immunology
Immunomodulation - drug effects
Immunosuppression - methods
Immunosuppressive Agents - therapeutic use
Inflammation - drug therapy
Subjects (LCSH)
Eye - Diseases
Eye - Diseases - Immunological aspects
Abstract
These guidelines, compiled by a panel of clinicians and scientists with a high level of expertise, aim to provide readers with the most up-to-date and comprehensive instructions on the treatment and prevention of ocular inflammation. All of the recommendations are explicitly linked to supporting evidence and graded according to the strength of that evidence, and the editors have made every effort to ensure that chapters are of a consistently high methodological quality. The guidelines for each treatment include dose and the frequency and mode of delivery. Significant side-effects of treatment are identified and distinguished from those of the disease in question. Suggestions are presented for the prevention both of the disease itself and of the treatment-related complications. In addition, likely future directions in treatment and prevention are identified.
Contents
Ocular Allergy -- Immune Modulation in Ocular Mucous Membrane Pemphigoid -- Diagnosis and Management of Scleritis -- Noninfectious Inflammation in Cataract Surgery -- Corneal Inflammation Following Excimer Laser Surgery -- Prevention and Treatment of Transplant Rejection in Keratoplasty -- Immunomodulation Against Inflammatory Postkeratoplasty Neovascularisation -- Treatment of Inflammation Secondary to Vitreoretinal Surgery -- Treatment of Intermediate Uveitis -- Posterior Uveitis -- Cystoid Macular Edema -- Safety of Immunosuppressive Therapy for Eye Diseases.
Format
e-Book
Location
Online
Less detail

Infections in solid-organ transplant recipients

https://libcat.nshealth.ca/en/permalink/provcat23550
Alangaden, George J. American Society for Microbiology. --Washington, DC: ASM Press , c2008.
Call Number
WC 195 I43 2008
Location
Halifax Infirmary
Call Number
WC 195 I43 2008
Author
Alangaden, George J
Corporate Author
American Society for Microbiology
Place of Publication
Washington, DC
Publisher
ASM Press
Date of Publication
c2008
Physical Description
63 p.
Series Vol.
45
Series Title
Cumitech
ISBN
9781555814496
Subjects (MeSH)
Organ Transplantation
Opportunistic Infections
Cross Infection
Immunosuppressive Agents - adverse effects
Format
Book
Location
Halifax Infirmary
Copies
2
Loan Period
3 weeks
Less detail

Methotrexate (MTX) therapy for inflammatory bowel disease (IBD)

https://libcat.nshealth.ca/en/permalink/chpams34942
Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1138
Available Online
View Pamphlet
Your health care provider feels that treatment with methotrexate (meth-oh-TREX-ate) might help your Crohn’s disease or ulcerative colitis. These are both types of inflammatory bowel disease (IBD). This pamphlet explains what methotrexate (MTX) is, how well it works, side effects of MTX, who should not take MTX, and precautions. Instructions for injecting MTX are given.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document (13 p.) : digital, PDF file
Subjects (MeSH)
Methotrexate
Crohn's disease
Inflammatory Bowel Diseases
Immunosuppressive Agents
Subjects (LCSH)
Crohn's disease
Methotrexate
Immunosuppressive agents
Inflammatory bowel diseases
Specialty
Gastrointestinal System
Medications
Abstract
Your health care provider feels that treatment with methotrexate (meth-oh-TREX-ate) might help your Crohn’s disease or ulcerative colitis. These are both types of inflammatory bowel disease (IBD). This pamphlet explains what methotrexate (MTX) is, how well it works, side effects of MTX, who should not take MTX, and precautions. Instructions for injecting MTX are given.
Responsibility
Prepared by: Nova Scotia Collaborative Inflammatory Bowel Disease Program
Pamphlet Number
1138
Less detail

Meyler's side effects of drugs used in cancer and immunology

https://libcat.nshealth.ca/en/permalink/provcat32091
editor, J.K. Aronson. --Amsterdam ; London: Elsevier Science , c2010.
Available Online
View e-Book
Access
Registration required for PDF access.
Location
Online
Elsevier now offers a series of derivative works based on the acclaimed Meyler's Side Effect of Drugs, 15th Edition. These individual volumes are grouped by specialty to benefit the practicing biomedical researcher and/or clinician.
Available Online
View e-Book
Other Authors
Aronson, J. K
Meyler, L
Responsibility
editor, J.K. Aronson
Alternate Title
Side effects of anticancer drugs
Place of Publication
Amsterdam ; London
Publisher
Elsevier Science
Date of Publication
c2010
Physical Description
1 online resource (viii, 774 p.)
ISBN
9780444532671 (hbk.)
Subjects (MeSH)
Antineoplastic Agents - adverse effects
Adjuvants, Immunologic - adverse effects
Immunosuppressive agents - adverse effects
Drug Interactions
Subjects (LCSH)
Cytostatic Agents - adverse effects
Anti-Allergic Agents - adverse effects
Drugs - Side effects
Cancer - Chemotherapy - Complications
Abstract
Elsevier now offers a series of derivative works based on the acclaimed Meyler's Side Effect of Drugs, 15th Edition. These individual volumes are grouped by specialty to benefit the practicing biomedical researcher and/or clinician.
Access
Registration required for PDF access.
Format
e-Book
Location
Online
Less detail

Polyoma virus and BK virus

https://libcat.nshealth.ca/en/permalink/chpams35425
Nova Scotia Health Authority. Kidney Transplant Clinic. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1510
Available Online
View Pamphlet
BK virus is a part of the polyoma virus family. About 80% of people carry the virus. People usually get this virus as children. It can stay inactive in your body without causing harm for many years. It can become active if you are immunocompromised (your immune system is weak). People who have had a kidney transplant and are taking immunosuppressive medications (medications that suppress [lower] your immune system) are at risk of infection from the virus. This pamphlet explains the symptoms of …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Kidney Transplant Clinic
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Polyomavirus
BK Virus
Kidney Transplantation - adverse effects
Immunosuppressive Agents - adverse effects
Subjects (LCSH)
Polyomaviruses
Kidneys--Transplantation
Immunosuppressive agents
Specialty
Nephrology
Medications
Abstract
BK virus is a part of the polyoma virus family. About 80% of people carry the virus. People usually get this virus as children. It can stay inactive in your body without causing harm for many years. It can become active if you are immunocompromised (your immune system is weak). People who have had a kidney transplant and are taking immunosuppressive medications (medications that suppress [lower] your immune system) are at risk of infection from the virus. This pamphlet explains the symptoms of BK virus, how BK virus is diagnosed, and how it is treated.
Responsibility
Prepared by: Kidney Transplant Clinic
Pamphlet Number
1510
Less detail

Skin disease in organ transplantation

https://libcat.nshealth.ca/en/permalink/provcat23548
Otley, Clark C. --Cambridge, England: Cambridge University Press , 2008.
Call Number
WR 140 S628 2008
Location
Dickson Building
Call Number
WR 140 S628 2008
Author
Otley, Clark C
Other Authors
Stasko, Thomas
Place of Publication
Cambridge, England
Publisher
Cambridge University Press
Date of Publication
2008
Physical Description
353 p.
ISBN
9780521870672
Subjects (MeSH)
Skin Diseases
Organ Transplantation - adverse effects
Immunosuppressive Agents - adverse effects
Format
Book
Location
Dickson Building
Loan Period
3 weeks
Less detail

Skin diseases in the immunocompromised

https://libcat.nshealth.ca/en/permalink/provcat34055
John C. Hall, editor. --London: Springer , c2014.
Available Online
View e-Book
Location
Online
As the number of surviving immune suppressed patients continues to rise, skin manifestations of patients have become increasingly important. AIDS patients, and renal, heart, liver, bone marrow, and lung transplant patients are now living longer and immunosuppressive drugs are being used more frequently. Diabetes is rising in the US and around the world, offering its own unique brand of immune suppressed skin diseases. The skin may be the earliest sign of these conditions and be the organ showin…
Available Online
View e-Book
Other Authors
Hall, John C.
Responsibility
John C. Hall, editor
Place of Publication
London
Publisher
Springer
Date of Publication
c2014
Physical Description
1 online resource (xvi, 191 pages)
ISBN
9781447164791 (electronic bk.)
9781447164784
Subjects (MeSH)
Immunocompromised Host
Immunosuppressive agents - adverse effects
Radiotherapy - adverse effects
Skin Diseases - immunology
Transplantation Immunology
Subjects (LCSH)
Skin - Diseases
Immunologic diseases
Dermatology
Infectious Diseases
Abstract
As the number of surviving immune suppressed patients continues to rise, skin manifestations of patients have become increasingly important. AIDS patients, and renal, heart, liver, bone marrow, and lung transplant patients are now living longer and immunosuppressive drugs are being used more frequently. Diabetes is rising in the US and around the world, offering its own unique brand of immune suppressed skin diseases. The skin may be the earliest sign of these conditions and be the organ showing the most profound, earliest, and treatment limiting side effects. Skin Diseases in the Immunocompromised is the most comprehensive book on the topic available. It elucidates the signs of immune suppressed skin diseases to afford early diagnosis and management of this ever-increasing diverse group of illnesses.
Contents
Part I. Disease Specific -- Skin Disorders in Immunocompromised Diabetes Patients -- Skin Disorders of AIDS Patients -- Skin Disorders in Patients with Primary Immunodeficiencies -- Cancer Patients and Skin Disease -- Part II. Transplant Patients -- Skin Disease in Solid Organ Transplant Patients -- Graft vs Host Disease and Skin Manifestations -- Part III. Drug Related -- Cutaneous Reactions to the Biologics -- Cutaneous Reactions to Chemotherapy -- Cutaneous Reactions to Corticosteroids -- Cutaneous Reactions to Tyrosine Kinase Inhibitors -- Part IV. Age Related -- Cutaneous Manifestations of Aging and Immunodeficiency -- Part V. Radiation -- UVA and UVB Therapy: Practical Applications and Implications for the Immunosuppressed Patient and Skin Disease -- Skin Cancer in the Immunocompromised -- Radiation Therapy for Non-melanoma Skin Cancer in Immunosuppressed Patients and Cutaneous Toxicity from This Therapy.
Format
e-Book
Location
Online
Less detail

Skin Diseases in the Immunosuppressed

https://libcat.nshealth.ca/en/permalink/provcat42882
edited by Oscar R. Colegio. --Cham, Switzerland: Springer , c2018.
Available Online
View e-Book
Location
Online
In this book, expert dermatologists review state of the art knowledge concerning the clinical presentation and management of cutaneous diseases that develop in immunosuppressed individuals, including transplant recipients, those with primary immunodeficiencies, and HIV sufferers. Throughout the book, correlations are made with iatrogenic, primary, and acquired immunodeficiencies. A major aim is to enable dermatologists to identify the specific immunosuppressant responsible for a specific advers…
Available Online
View e-Book
Other Authors
Colegio, Oscar R.
Responsibility
edited by Oscar R. Colegio
Place of Publication
Cham, Switzerland
Publisher
Springer
Date of Publication
c2018
Physical Description
1 online resource (x, 211 p.) : 49 illus. in color
ISBN
9783319687902
9783319687889 (print ed.)
9783319687896 (print ed.)
Subjects (MeSH)
Immunocompromised Host
Immunosuppressive Agents - adverse effects
Radiotherapy - adverse effects
Skin Diseases
Transplantation Immunology
Specialty
Allergy and Immunology
Dermatology
Abstract
In this book, expert dermatologists review state of the art knowledge concerning the clinical presentation and management of cutaneous diseases that develop in immunosuppressed individuals, including transplant recipients, those with primary immunodeficiencies, and HIV sufferers. Throughout the book, correlations are made with iatrogenic, primary, and acquired immunodeficiencies. A major aim is to enable dermatologists to identify the specific immunosuppressant responsible for a specific adverse effect, whether benign or malignant, in patients receiving a complex medication regimen in the setting of transplantation. Further, the book will help the dermatologist to distinguish the cutaneous adverse effects of antiviral agents from effects arising directly from advancing HIV disease. Recognition of the cutaneous manifestations of often less common primary immunodeficiencies will also be emphasized. A final goal is to improve patient outcomes by providing dermatologists with treatment strategies for skin disease arising in the immunosuppressed state. This book will be invaluable for a broad audience, from practicing dermatologists to medical and dermatology residents.
Contents
The Immune System: Structure, Function, and Roles in Skin Disease -- Skin Diseases in Primary Immunodeficiencies -- Skin Diseases Associated with HIV Disease -- Benign Cutaneous Eruptions After Transplantation -- Cutaneous Malignancies in Solid Organ Transplant Recipients -- Skin Diseases Associated with Stem Cell Transplantation -- Skin Cancers Associated With Lymphoid Malignancies -- Skin Diseases Associated with Biologic Therapies -- Virally Induced Cancers -- Immunosenescence and Cutaneous Malignancies.
Format
e-Book
Location
Online
Less detail

13 records – page 1 of 1.